Search Results - "MUKHERJI, Bijay"

Refine Results
  1. 1

    Immunology of melanoma by Mukherji, Bijay, MD

    Published in Clinics in dermatology (01-03-2013)
    “…Abstract It can be safely said that human melanomas are immunogenic. Virtually all the major principles of “tumor immunology” have been experimentally…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Medical Education: The Hot Seat by Pal, Ranabir, Kumar, Raman, Pal, Shrayan, Mukherji, Bijay, Debabrata, Sarbapalli

    “…Medical science has eventually metamorphosed from ′Knowledge based′ to ′Skill based′ applied social science. So, the age-old traditional courses and…”
    Get full text
    Journal Article
  4. 4

    Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death by Mehrotra, Shikhar, Chhabra, Arvind, Hegde, Upendra, Chakraborty, Nitya G., Mukherji, Bijay

    Published in Journal of leukocyte biology (01-02-2007)
    “…Cytolytic T lymphocytes (CTL) play an important role in defense against viral infections. Following clonal expansion and effector functions, a vast majority of…”
    Get full text
    Journal Article
  5. 5

    Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma by Ray, Swagatam, PhD, Chhabra, Arvind, PhD, Mehrotra, Shikhar, PhD, Chakraborty, Nitya G., PhD, Ribas, Antoni, MD, Economou, James, MD, PhD, Mukherji, Bijay, MD

    Published in Clinics in dermatology (01-11-2009)
    “…Abstract Melanoma cells can play a number of tricks to evade the host immune response. They can make themselves invisible to cells of the immune system poised…”
    Get full text
    Journal Article
  6. 6

    Cross‐presentation of a human tumor antigen delivered to dendritic cells by HSV VP22‐mediated protein translocation by Chhabra, Arvind, Mehrotra, Shikhar, Chakraborty, Nitya G., Mukherji, Bijay, Dorsky, David I.

    Published in European journal of immunology (01-10-2004)
    “…Dendritic cells (DC) capture antigens from apoptotic and/or necrotic tumor cells and cross‐present them to T cells, and various ways of delivering tumor…”
    Get full text
    Journal Article
  7. 7

    Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T Cells by Chhabra, Arvind, Mukherji, Bijay

    Published in Human immunology (01-10-2016)
    “…Abstract Regulatory T cells (Treg) can interfere with the generation and function of anti-tumor immune effectors. Accordingly, ways that could block Treg…”
    Get full text
    Journal Article
  8. 8

    Death receptor-independent activation-induced cell death in human melanoma antigen-specific MHC class I-restricted TCR-engineered CD4 T cells by Chhabra, Arvind, Mukherji, Bijay

    Published in The Journal of immunology (1950) (15-09-2013)
    “…Engaging CD4 T cells in antitumor immunity has been quite challenging, especially in an Ag-specific manner, because most human solid tumors usually do not…”
    Get full text
    Journal Article
  9. 9

    Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies by Hegde, Upendra P., Mukherji, Bijay

    Published in Cancer Immunology, Immunotherapy (01-09-2017)
    “…Adoptive cell therapies with chimeric antigen receptor (CAR) engineered T cells (CAR-T) and immune checkpoint inhibition (ICI)-based cancer immunotherapies…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53 by Chhabra, Arvind, Mukherji, Bijay, Batra, Deepika

    Published in Expert opinion on therapeutic targets (01-02-2017)
    “…Adoptive cancer immunotherapy (ACT) with transgenic T cell receptor (TCR) engineered (TCReng) anti-tumor T cells has produced encouraging results, however,…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Knockdown of T‐bet expression in Mart‐1 27–35 ‐specific T ‐cell‐receptor‐engineered human CD 4 +  CD25 − and CD 8 + T cells attenuates effector function by Jha, Sidharth S., Chakraborty, Nitya G., Singh, Prashant, Mukherji, Bijay, Dorsky, David I.

    Published in Immunology (01-05-2015)
    “…Gene transfer to create tumour epitope‐specific cytolytic T cells for adoptive immunotherapy of cancer remains an area of active inquiry. When the Mart‐1 27–35…”
    Get full text
    Journal Article
  14. 14

    Abstract 3569: Transcriptional signatures in human melanoma epitope MART-127-35 specific TCR-engineered T cells by Singh, Prashant, Chakraborty, Nitya G., Farooq, Umar, Hegde, Upendra P., Everson, Richard, Dorsky, David I., Mukherji, Bijay

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Adoptive Cell Therapies (ACT) with T cell receptor-engineered (TCReng) T cells have shown promising results. Unfortunately, for a fuller understanding of their…”
    Get full text
    Journal Article
  15. 15

    Abstract 4982: Comparison of T cell responses to a melanoma-related antigen in elderly and young melanoma patients by Chakraborty, Nitya G., Singh, Prashant, Dadras, Soheil S., Mukherji, Bijay, Hegde, Upendra P.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…It is widely believed that a hypo-and/or dysfunctional state in T cells in the elderly is a negative factor in immune defense against cancer. Accordingly,…”
    Get full text
    Journal Article
  16. 16

    Regulatory T cells and tumor immunity by CHATTOPADHYAY, Subhasis, CHAKRABORTY, Nitya G, MUKHERJI, Bijay

    Published in Cancer Immunology, Immunotherapy (01-12-2005)
    “…Central deletion of "self-reactive" T cells has been the textbook paradigm for inducing "self-tolerance" in the periphery and the concept of a role of T…”
    Get full text
    Journal Article
  17. 17

    Stimulatory and inhibitory maturation of human macrophage-derived dendritic cells by Chakraborty, A, Li, L, Chakraborty, N G, Mukherji, B

    Published in Pathobiology (Basel) (01-01-1999)
    “…Circulating human macrophages are often used to generate dendritic cells (DCs) by culturing them in granulocyte macrophage-colony stimulating factor (GM-CSF)…”
    Get more information
    Journal Article
  18. 18

    Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-127–35 by Chhabra, Arvind, Chakraborty, Nitya G, Mukherji, Bijay

    Published in Clinical immunology (Orlando, Fla.) (01-03-2008)
    “…Abstract Dendritic cells (DC) present antigenic epitopes to and activate T cells. They also polarize the ensuing T cell response to Th1 or Th2 type response,…”
    Get full text
    Journal Article
  19. 19

    Knockdown of T‐bet expression in Mart‐127–35‐specific T‐cell‐receptor‐engineered human CD4+ CD25− and CD8+ T cells attenuates effector function by Jha, Sidharth S., Chakraborty, Nitya G., Singh, Prashant, Mukherji, Bijay, Dorsky, David I.

    Published in Immunology (01-05-2015)
    “…Summary Gene transfer to create tumour epitope‐specific cytolytic T cells for adoptive immunotherapy of cancer remains an area of active inquiry. When the…”
    Get full text
    Journal Article
  20. 20

    Analyses of the immunologically relevant gene transcript by qRT-PCR in primary cutaneous melanoma by the young and the elderly by Hegde, Upendra P., Dadras, Soheil Sam, Kerr, Phil, Chakraborty, Nitya, grant-Kels, Jane, Mukherji, Bijay

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e21135 Background: To understand the dynamics of anti tumor immune responses (IR) in the setting of the ageing immune system, we examined…”
    Get full text
    Journal Article